Get App
Moneycontrol

Co-Partners

Associate Partners

you are here: HomeNewsWorld
Last Updated : May 14, 2019 04:59 PM IST | Source: Moneycontrol.com

Reporter's Take | Anti-trust case spooks Indian generic drug companies

Stanford Masters chats with Moneycontrol's Viswanath Pilla to understand if there is any substance to these allegations.

Moneycontrol News @moneycontrolcom

Stocks of Indian pharmaceutical companies tanked after the second anti-trust case against 20 pharma companies in US.

This lawsuit seeks expansion of the case as they claim to have more evidence of the wrongdoings by the company.

Stanford Masters chats with Moneycontrol's Viswanath Pilla to understand if there is any substance to these allegations.

Get Lok Sabha 2019 Live Election Results, constituency-wise tally, news, views and analysis
Follow our Lok Sabha Election Result Live Blog here.
First Published on May 14, 2019 04:59 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant